Protalex Inc. (PRTX) Insider Arnold P. Kling Purchases 18,557,805 Shares
Protalex Inc. (OTCMKTS:PRTX) insider Arnold P. Kling bought 18,557,805 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The stock was bought at an average price of $1.20 per share, for a total transaction of $22,269,366.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of Protalex Inc. (OTCMKTS PRTX) opened at $0.55 on Monday. Protalex Inc. has a 12-month low of $0.31 and a 12-month high of $3.00.
Protalex Company Profile
Protalex, Inc is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company’s lead product candidate, PRTX-100, is a formulation of the Staphylococcal bacterial protein known as Protein A, which modifies aspects of the human immune system.
Receive News & Ratings for Protalex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protalex and related companies with MarketBeat.com's FREE daily email newsletter.